Business Description
Magenta Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US55910K1088
Compare
Compare
Traded in other countries / regions
3MT.Germany IPO Date
2018-06-21Description
Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to extend the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy. The pipeline of the company includes MGTA-117, MGTA-145, MGTA-45 and others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.53 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-Equity | 0.41 | |||||
| Debt-to-EBITDA | -0.52 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 14 | |||||
| 3-Year EPS without NRI Growth Rate | 13.2 | |||||
| 3-Year FCF Growth Rate | 9.8 | |||||
| 3-Year Book Growth Rate | -20.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 7.33 | |||||
| 12-1 Month Momentum % | -58.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 19.5 | |||||
| Quick Ratio | 19.5 | |||||
| Cash Ratio | 19.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.6 | |||||
| Shareholder Yield % | -0.14 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -66.23 | |||||
| ROA % | -52.83 | |||||
| ROIC % | -163.53 | |||||
| 3-Year ROIIC % | -7.77 | |||||
| ROC (Joel Greenblatt) % | -191.77 | |||||
| ROCE % | -48.96 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.6 | |||||
| Price-to-Tangible-Book | 0.57 | |||||
| EV-to-EBIT | 0.58 | |||||
| EV-to-EBITDA | 0.6 | |||||
| EV-to-FCF | 0.47 | |||||
| Price-to-Net-Current-Asset-Value | 0.57 | |||||
| Price-to-Net-Cash | 0.58 | |||||
| Earnings Yield (Greenblatt) % | 172.41 | |||||
| FCF Yield % | -175.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MGTA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Magenta Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.14 | ||
| Beta | 0 | ||
| Volatility % | 100.57 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.053082 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | -58.29 | ||
| 52-Week Range ($) | 0.321 - 2.065 | ||
| Shares Outstanding (Mil) | 60.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Magenta Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Magenta Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Magenta Therapeutics Inc Frequently Asked Questions
What is Magenta Therapeutics Inc(MGTA)'s stock price today?
The current price of MGTA is $0.70. The 52 week high of MGTA is $2.07 and 52 week low is $0.32.
When is next earnings date of Magenta Therapeutics Inc(MGTA)?
The next earnings date of Magenta Therapeutics Inc(MGTA) is 2025-05-15 Est..
Does Magenta Therapeutics Inc(MGTA) pay dividends? If so, how much?
Magenta Therapeutics Inc(MGTA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers